GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Wuxi AppTec Co Ltd (HKSE:02359) » Definitions » Cash Flow for Dividends

Wuxi AppTec Co (HKSE:02359) Cash Flow for Dividends : HK$-3,331 Mil (TTM As of Dec. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Wuxi AppTec Co Cash Flow for Dividends?

Wuxi AppTec Co's cash flow for dividends for the three months ended in Dec. 2024 was HK$-38 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2024 was HK$-3,331 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Wuxi AppTec Co's quarterly payment of dividends declined from Jun. 2024 (HK$-2,821 Mil) to Sep. 2024 (HK$-450 Mil) and declined from Sep. 2024 (HK$-450 Mil) to Dec. 2024 (HK$-38 Mil).

Wuxi AppTec Co's annual payment of dividends increased from Dec. 2022 (HK$-1,785 Mil) to Dec. 2023 (HK$-3,014 Mil) and increased from Dec. 2023 (HK$-3,014 Mil) to Dec. 2024 (HK$-3,294 Mil).

Wuxi AppTec Co Cash Flow for Dividends Historical Data

The historical data trend for Wuxi AppTec Co's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wuxi AppTec Co Cash Flow for Dividends Chart

Wuxi AppTec Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only -756.44 -1,117.63 -1,784.99 -3,014.23 -3,293.64

Wuxi AppTec Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -24.33 -22.61 -2,820.75 -450.04 -37.51

Wuxi AppTec Co Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$-3,331 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Wuxi AppTec Co Cash Flow for Dividends Related Terms

Thank you for viewing the detailed overview of Wuxi AppTec Co's Cash Flow for Dividends provided by GuruFocus.com. Please click on the following links to see related term pages.

Wuxi AppTec Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Wuxi AppTec Co Ltd (HKSE:02359) » Definitions » Cash Flow for Dividends
Comparable Companies
SZSE:300347 SZSE:300676 SHSE:603882 SHSE:603127 SHSE:603108 SZSE:300244 SZSE:300406 SZSE:300685 SZSE:300463 SZSE:000710 TMO DHR XSWX:LONN IDXX A IQV MTD WAT NTRA LH
Traded in Other Exchanges
WUXIF:USA WUXAY:USA WX8:Germany 603259:China
Address
288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Pudong New Area, Shanghai, CHN, 200131
Website
https://www.wuxiapptec.com
Wuxi AppTec Co Ltd provides a portfolio of research and manufacturing services throughout the discovery, development, and manufacturing spectrum for small molecule drugs, development of computer software and databases as well as consulting services for combinatorial chemistry and pharmaceuticals. The services offered by the company include drug research and development testing, clinical research services, an end-to-end CRDMO platform for peptide, oligonucleotide, and small molecules, and integrated biology services and solutions for drug discovery. The company's reportable segments are WuXi Chemistry, which derives maximum revenue, WuXi Testing, WuXi Biology, and Others. Geographically, it derives key revenue from the United States of America, followed by China, Europe, and other regions.
Executives
Jpmorgan Chase & Co.
Fmr Llc 2201 Interest of corporation controlled by you
Ubs Group Ag 2201 Interest of corporation controlled by you
Morgan Stanley 2201 Interest of corporation controlled by you
Blackrock, Inc. 2201 Interest of corporation controlled by you
Citigroup Inc. 2201 Interest of corporation controlled by you
Schroders Plc 2102 Investment manager
Computershare Hong Kong Trustees Limited 2301 Trustee
The Capital Group Companies, Inc. 2201 Interest of corporation controlled by you
The Goldman Sachs Group, Inc.
Brown Brothers Harriman & Co. 2502 Approved lending agent
Pandanus Partners L.p. 2201 Interest of corporation controlled by you
Pandanus Associates Inc. 2201 Interest of corporation controlled by you
Fil Limited 2201 Interest of corporation controlled by you
Bank Of America Corporation

Wuxi AppTec Co Headlines

No Headlines